Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chronic Health has maintained a consistent performance in the Arizona market, particularly in the Tincture & Sublingual category, where it has held the second rank from August through November 2025. Despite this stability in ranking, there has been a noticeable decline in sales figures, from $21,239 in August to $17,354 in November. This trend suggests a potential challenge in maintaining consumer interest or facing increased competition. Conversely, in the Topical category, Chronic Health experienced a decline in ranking from second to fifth place over the same period. However, sales figures show a rebound from September to November, indicating a possible recovery or successful strategic adjustments.
While Chronic Health's performance in Arizona provides valuable insights, the absence of rankings in other states or categories where they are not in the top 30 suggests areas where the brand might be struggling or less competitive. The lack of presence in these rankings could point to opportunities for growth or highlight markets where Chronic Health has yet to establish a significant footprint. This disparity in performance across categories and states underscores the importance of strategic focus and adaptation to market dynamics. Chronic Health's ability to sustain and improve its position in Arizona could serve as a model for expansion into other regions.
Competitive Landscape
In the competitive landscape of the Topical category in Arizona, Chronic Health has experienced some notable shifts in its market position over recent months. From August to November 2025, Chronic Health's rank dropped from 2nd to 5th, indicating a competitive challenge from other brands. Notably, Tru Infusion has shown a significant upward trajectory, moving from 5th to 3rd place, which suggests a strong increase in consumer preference or market penetration. Meanwhile, iLava maintained a consistent 4th place ranking throughout this period, demonstrating stable performance. Despite the rank drop, Chronic Health's sales figures remained relatively stable, suggesting that while competitors are gaining ground, Chronic Health still holds a significant share of the market. Brands like Gramz and DermaFreeze have not posed a significant threat, with Gramz maintaining a 6th place position and DermaFreeze dropping out of the top 20 after September. This competitive environment highlights the need for Chronic Health to innovate and strategize to reclaim its higher market position.

Notable Products
In November 2025, the top-performing product for Chronic Health was the Indica THC Glycerin Tincture (100mg THC, 1oz) in the Tincture & Sublingual category, maintaining its number one rank for four consecutive months with sales of 499 units. The CBD/THC 1:1 Glycerin Tincture (100mg CBD, 100mg THC, 1oz) also held steady at the second position, showing a slight increase in sales. The CBD/THC 1:1 Pain Relief Ointment (175mg CBD, 175mg THC, 2oz) advanced to third place, up from the fourth position in previous months, indicating growing consumer interest. Meanwhile, the CBD/THC 1:1 Sleep Well Tincture (100mg CBD, 100mg THC, 1oz) dropped to fourth place, showing a consistent decline in sales from August to November. The CBD/THC 1:1 Pain Relief Ointment (45mg CBD, 45mg THC) remained in fifth place but experienced a steady increase in sales figures month over month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







